- Report
- May 2025
- 171 Pages
Global
From €5359EUR$5,850USD£4,555GBP
- Report
- May 2025
- 194 Pages
Global
From €5359EUR$5,850USD£4,555GBP
- Report
- December 2024
- 204 Pages
Global
From €2290EUR$2,500USD£1,946GBP
- Report
- January 2025
- 182 Pages
Global
From €4122EUR$4,500USD£3,504GBP
- Report
- July 2024
- 150 Pages
Global
From €3435EUR$3,750USD£2,920GBP
- Report
- December 2024
- 135 Pages
Global
From €3618EUR$3,950USD£3,075GBP
- Report
- August 2024
- 200 Pages
Global
From €4534EUR$4,949USD£3,853GBP
- Report
- July 2024
- 154 Pages
Global
From €3309EUR$3,613USD£2,813GBP
€3893EUR$4,250USD£3,309GBP
- Report
- May 2024
- 70 Pages
United States
From €3618EUR$3,950USD£3,075GBP
- Report
- January 2025
- 135 Pages
United States
From €2281EUR$2,490USD£1,939GBP
- Report
- August 2024
- 310 Pages
Europe
From €2281EUR$2,490USD£1,939GBP
- Report
- October 2024
- 88 Pages
Latin America
From €3160EUR$3,450USD£2,686GBP
- Report
- August 2023
- 1500 Pages
Global
From €8016EUR$8,750USD£6,812GBP
- Report
- March 2022
- 312 Pages
Global
From €6412EUR$7,000USD£5,450GBP
- Report
- March 2021
- 54 Pages
Global
From €2748EUR$3,000USD£2,336GBP
- Report
- October 2023
- 382 Pages
Global
From €4534EUR$4,950USD£3,854GBP
- Report
- February 2023
- 127 Pages
Global
From €1603EUR$1,750USD£1,362GBP
€2290EUR$2,500USD£1,946GBP
- Report
- August 2023
- 389 Pages
Global
From €3825EUR$4,175USD£3,250GBP
- Report
- December 2022
- 120 Pages
Italy
From €3618EUR$3,950USD£3,075GBP
- Report
- May 2023
- 180 Pages
Germany
From €2739EUR$2,990USD£2,328GBP

Radioimmunoassay (RIA) is a laboratory technique used to measure the concentration of antigens, such as hormones, in a sample. In the context of oncology drugs, RIA is used to measure the concentration of tumor markers in the blood, which can help diagnose and monitor cancer. RIA can also be used to measure the concentration of therapeutic drugs in the blood, which can help determine the effectiveness of a drug and its dosage.
RIA is a highly sensitive and specific technique, and is used in many clinical laboratories. It is also used in research laboratories to study the pharmacokinetics of drugs, and to develop new drugs.
In the oncology drug market, RIA is used to measure the concentration of therapeutic drugs in the blood, and to monitor the effectiveness of the drug. It is also used to measure the concentration of tumor markers in the blood, which can help diagnose and monitor cancer.
Some companies in the RIA market for oncology drugs include Abbott Laboratories, Beckman Coulter, Siemens Healthcare, and Roche Diagnostics. Show Less Read more